Gilead Sciences
GILD
155.60
+2.53
+1.65%
Gilead Sciences
US · GILD
#110 by market cap
Listed 1992
155.60
+2.53
+1.65%
Live - 5344 symbols - heartbeat 472s ago
· 2026-10-20 10:49
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company focused on HIV, liver disease, hematology, oncology, and inflammatory and respiratory conditions, selling antiviral treatments under brands including Harvoni, Biktarvy-era successors to Truvada and Atripla, and Sovaldi. Michael Riordan founded the company on June 22, 1987; it is headquartered in Foster City, California.
- Founded
- 1987
- CEO
- Mr. Daniel P. O'Day
- Employees
- 17,000
- Headquarters
- Foster City, California, United States of America
- Fiscal year end
- 12-31
- Website
- gilead.com
Company profile
- Exchange
- US
- Symbol
- GILD
- Market-cap rank
- #110
- Listing date
- 1992-01-24
- Market cap
- 192.94B
- Float cap
- 192.52B
- Shares out
- 1.24B
- Float shares
- 1.24B
Sectors & themes
CAR-T Therapy
Infectious Disease
Cancer Research
Mpox (monkeypox)
Drug Manufacturers - General
Global medical industry
Regular Savings Plan
Fractional Shares JP
Quote time 2026-10-20 10:49:52 · For reference only, not investment advice and not tailored to your situation.
Gilead Sciences discussion 0 comments